Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05210361 · ClinicalTrials.gov registry record
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers
A clinical trial of Asthma in Children and Wheezing, sponsored by University of Colorado, Denver.
- Active
- Registry status
- 192
- Enrollment target
- 1
- Study location
NCT05210361: Active study of Asthma in Children and Wheezing, sponsored by University of Colorado, Denver.
NCT05210361 is a study of Asthma in Children and Wheezing that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 192 participants, roughly in line with the 201-participant average among 44 other Asthma in Children trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05210361, a study of Asthma in Children and Wheezing, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about how asthma develops in early childhood. This will help doctors understand how to prevent and treat asthma better.
Primary Outcome
Children will be classified as having persistent asthma if at least 1 of the following 3 conditions are met: 1. Doctor Diagnosis: a parent-reported physician's diagnosis of asthma between age 4 and 7 years plus asthma symptoms or the use of asthma controller medication for at least 6 of the past 12 months 2. Lung Function: bronchodilator-induced improvement of forced expiratory volume in 1 second (FEV1) by 10% or more plus asthma symptoms or use of asthma controller medication for at least 6 of
Conditions Studied
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2027-07 |
What the registry record for NCT05210361 still lists
NCT05210361 is an observational study that tracks outcomes without assigning an intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 201-participant average among 44 other Asthma in Children trials with a reported enrollment target.
The record links to 2 conditions, with Asthma in Children appearing as the primary indexed condition, and to 0 interventions.
NCT05210361 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05210361 about?
NCT05210361 is a clinical study titled "Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers". The purpose of this study is to learn more about how asthma develops in early childhood. This will help doctors understand how to prevent and treat asthma better.
What is the current status of trial NCT05210361?
This trial is currently active not recruiting. The enrollment target is 192 participants. The study started on 2022-02-14. Estimated completion is 2027-07.
What conditions does trial NCT05210361 study?
This clinical trial studies the following conditions: Asthma in Children, Wheezing.
Who is sponsoring clinical trial NCT05210361?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05210361 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05210361's enrollment target sits among peer trials
192 18th of 44 higher than 27 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
Wearable Electronic Breath Sound Sensing Device
RECRUITING
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI